Loading...
Loading...
OLK| Name | Value |
|---|---|
| Revenues | 69.3M |
| Cost of Revenue | 20.1M |
| Gross Profit | 49.2M |
| Operating Expense | 55.4M |
| Operating I/L | -6.2M |
| Other Income/Expense | -3.6M |
| Interest Income | 1.4M |
| Pretax | -9.8M |
| Income Tax Expense | -2.2M |
| Net Income/Loss | -7.6M |
Olink Holding AB (publ) offers products and services for life science research institutions, including Olink Explore for various diseases, Olink Target and Olink Focus product lines, Olink Signature Q100 platform, Olink Analysis and bioinformatics services, Olink normalized protein expression (NPX) Manager, and Olink Insight cloud platform. The company generates revenue by selling these products and services through its direct sales force in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
